Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
3.830
+0.020 (0.52%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $408.55 million as of September 25, 2026. Its market cap has increased by 645.52% in one year.
Market Cap
408.55M
Enterprise Value
190.81M
1-Year Change
645.52%
Ranking
Category
Stock Price
$3.83
ChartMarket Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $408.55M, an increase of 621.81%. That is a compound annual growth rate of 19.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 408.55M | 15.34% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 417.87M |
| ARS Pharmaceuticals | 415.69M |
| Zura Bio | 414.94M |
| Editas Medicine | 413.13M |
| Galectin Therapeutics | 408.44M |
| DiaMedica Therapeutics | 407.68M |
| Larimar Therapeutics | 403.44M |
| Turn Therapeutics | 402.44M |